CRNX
Price
$30.04
Change
+$0.05 (+0.17%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
2.81B
42 days until earnings call
ZBIO
Price
$9.56
Change
-$0.59 (-5.81%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
424.62M
68 days until earnings call
Interact to see
Advertisement

CRNX vs ZBIO

Header iconCRNX vs ZBIO Comparison
Open Charts CRNX vs ZBIOBanner chart's image
Crinetics Pharmaceuticals
Price$30.04
Change+$0.05 (+0.17%)
Volume$93.19K
Capitalization2.81B
Zenas Biopharma
Price$9.56
Change-$0.59 (-5.81%)
Volume$14.33K
Capitalization424.62M
CRNX vs ZBIO Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. ZBIO commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and ZBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CRNX: $29.99 vs. ZBIO: $10.15)
Brand notoriety: CRNX and ZBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 70% vs. ZBIO: 87%
Market capitalization -- CRNX: $2.81B vs. ZBIO: $424.62M
CRNX [@Biotechnology] is valued at $2.81B. ZBIO’s [@Biotechnology] market capitalization is $424.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileZBIO’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • ZBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, ZBIO is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while ZBIO’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 6 bearish.
  • ZBIO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ZBIO is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -1.67% price change this week, while ZBIO (@Biotechnology) price change was +9.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

ZBIO is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.81B) has a higher market cap than ZBIO($425M). ZBIO YTD gains are higher at: 23.932 vs. CRNX (-41.346). ZBIO has higher annual earnings (EBITDA): -173.51M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. ZBIO (312M). ZBIO has less debt than CRNX: ZBIO (1.23M) vs CRNX (50.8M). ZBIO has higher revenues than CRNX: ZBIO (15M) vs CRNX (760K).
CRNXZBIOCRNX / ZBIO
Capitalization2.81B425M661%
EBITDA-373.49M-173.51M215%
Gain YTD-41.34623.932-173%
P/E RatioN/AN/A-
Revenue760K15M5%
Total Cash1.27B312M408%
Total Debt50.8M1.23M4,147%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXZBIO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
76%
Bullish Trend 3 days ago
89%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VENAX59.70N/A
N/A
Vanguard Energy Index Admiral
BIGRX36.67N/A
N/A
American Century Discplnd Cor Val Inv
CAPRX8.85N/A
N/A
Federated Hermes Capital Income R
AXVNX17.31N/A
N/A
Acclivity Small Cap Value N
MENIX9.29N/A
N/A
Madison Covered Call & Equity Income I

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-1.38%
XNCR - CRNX
58%
Loosely correlated
-1.87%
TRDA - CRNX
57%
Loosely correlated
-0.57%
IDYA - CRNX
56%
Loosely correlated
+1.27%
RVMD - CRNX
55%
Loosely correlated
-2.42%
DYN - CRNX
55%
Loosely correlated
-3.55%
More

ZBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBIO has been loosely correlated with REPL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBIO jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBIO
1D Price
Change %
ZBIO100%
-0.39%
REPL - ZBIO
39%
Loosely correlated
+0.11%
KURA - ZBIO
32%
Poorly correlated
-1.21%
CRNX - ZBIO
31%
Poorly correlated
-1.38%
SNDX - ZBIO
31%
Poorly correlated
+4.49%
IMNM - ZBIO
30%
Poorly correlated
+1.27%
More